Hyperlipidemia has been shown to result in glomerular Apo-B accumulation, glomerular hypertrophy, increasing urine albumin, elevating transforming growth factor (TGF-β) levels, and continuous renal injury [27, 28]. Here, TGFB1 is linked to hyperlipidemia.